Literature DB >> 17515920

Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers.

Richard S Maser1, Bhudipa Choudhury, Peter J Campbell, Bin Feng, Kwok-Kin Wong, Alexei Protopopov, Jennifer O'Neil, Alejandro Gutierrez, Elena Ivanova, Ilana Perna, Eric Lin, Vidya Mani, Shan Jiang, Kate McNamara, Sara Zaghlul, Sarah Edkins, Claire Stevens, Cameron Brennan, Eric S Martin, Ruprecht Wiedemeyer, Omar Kabbarah, Cristina Nogueira, Gavin Histen, Jon Aster, Marc Mansour, Veronique Duke, Letizia Foroni, Adele K Fielding, Anthony H Goldstone, Jacob M Rowe, Yaoqi A Wang, A Thomas Look, Michael R Stratton, Lynda Chin, P Andrew Futreal, Ronald A DePinho.   

Abstract

Highly rearranged and mutated cancer genomes present major challenges in the identification of pathogenetic events driving the neoplastic transformation process. Here we engineered lymphoma-prone mice with chromosomal instability to assess the usefulness of mouse models in cancer gene discovery and the extent of cross-species overlap in cancer-associated copy number aberrations. Along with targeted re-sequencing, our comparative oncogenomic studies identified FBXW7 and PTEN to be commonly deleted both in murine lymphomas and in human T-cell acute lymphoblastic leukaemia/lymphoma (T-ALL). The murine cancers acquire widespread recurrent amplifications and deletions targeting loci syntenic to those not only in human T-ALL but also in diverse human haematopoietic, mesenchymal and epithelial tumours. These results indicate that murine and human tumours experience common biological processes driven by orthologous genetic events in their malignant evolution. The highly concordant nature of genomic events encourages the use of genomically unstable murine cancer models in the discovery of biological driver events in the human oncogenome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515920      PMCID: PMC2714968          DOI: 10.1038/nature05886

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  50 in total

1.  Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations.

Authors:  Chengming Zhu; Kevin D Mills; David O Ferguson; Charles Lee; John Manis; James Fleming; Yijie Gao; Cynthia C Morton; Frederick W Alt
Journal:  Cell       Date:  2002-06-28       Impact factor: 41.582

2.  Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase.

Authors:  Stephen Orlicky; Xiaojing Tang; Andrew Willems; Mike Tyers; Frank Sicheri
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

Review 3.  ATM: genome stability, neuronal development, and cancer cross paths.

Authors:  Y Shiloh; M B Kastan
Journal:  Adv Cancer Res       Date:  2001       Impact factor: 6.242

Review 4.  Mechanisms of tumor suppression by the SCF(Fbw7).

Authors:  Alex C Minella; Bruce E Clurman
Journal:  Cell Cycle       Date:  2005-10-27       Impact factor: 4.534

5.  Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas.

Authors:  G Hodgson; J H Hager; S Volik; S Hariono; M Wernick; D Moore; N Nowak; D G Albertson; D Pinkel; C Collins; D Hanahan; J W Gray
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

6.  Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.

Authors:  K L Rudolph; M Millard; M W Bosenberg; R A DePinho
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

7.  Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.

Authors:  S E Artandi; S Chang; S L Lee; S Alson; G J Gottlieb; L Chin; R A DePinho
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

8.  Telomere dysfunction provokes regional amplification and deletion in cancer genomes.

Authors:  Rónán C O'Hagan; Sandy Chang; Richard S Maser; Ramya Mohan; Steven E Artandi; Lynda Chin; Ronald A DePinho
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

9.  Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing.

Authors:  Kwok-Kin Wong; Richard S Maser; Robert M Bachoo; Jayant Menon; Daniel R Carrasco; Yansong Gu; Frederick W Alt; Ronald A DePinho
Journal:  Nature       Date:  2003-01-22       Impact factor: 49.962

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  209 in total

Review 1.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

2.  Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.

Authors:  Todd D Ashworth; Warren S Pear; Mark Y Chiang; Stephen C Blacklow; Jérôme Mastio; Lanwei Xu; Michelle Kelliher; Philippe Kastner; Susan Chan; Jon C Aster
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

Review 3.  Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.

Authors:  Vathany Kulasingam; Maria P Pavlou; Eleftherios P Diamandis
Journal:  Nat Rev Cancer       Date:  2010-04-12       Impact factor: 60.716

4.  Anaplastic plasmacytoma of mouse--establishing parallels between subtypes of mouse and human plasma cell neoplasia.

Authors:  Daphne de Jong; Siegfried Janz
Journal:  J Pathol       Date:  2010-07       Impact factor: 7.996

Review 5.  Chromosomes and cancer cells.

Authors:  Sarah L Thompson; Duane A Compton
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

Review 6.  Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.

Authors:  Alea A Mills
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

7.  Modeling Genomic Instability and Selection Pressure in a Mouse Model of Melanoma.

Authors:  Lawrence N Kwong; Lihua Zou; Sharmeen Chagani; Chandra Sekhar Pedamallu; Mingguang Liu; Shan Jiang; Alexei Protopopov; Jianhua Zhang; Gad Getz; Lynda Chin
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

Review 8.  Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.

Authors:  Chandrika Gowda; Chunhua Song; Malika Kapadia; Jonathon L Payne; Tommy Hu; Yali Ding; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2016-09-18

9.  Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.

Authors:  Syed J Kazmi; Stephanie J Byer; Jenell M Eckert; Amy N Turk; Richard P H Huijbregts; Nicole M Brossier; William E Grizzle; Fady M Mikhail; Kevin A Roth; Steven L Carroll
Journal:  Am J Pathol       Date:  2013-01-13       Impact factor: 4.307

10.  Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia.

Authors:  Takaomi Sanda; Xiaoyu Li; Alejandro Gutierrez; Yebin Ahn; Donna S Neuberg; Jennifer O'Neil; Peter R Strack; Christopher G Winter; Stuart S Winter; Richard S Larson; Harald von Boehmer; A Thomas Look
Journal:  Blood       Date:  2009-12-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.